NxStage Medical, Inc. (NXTM) Financial Statements (2024 and earlier)

Company Profile

Business Address 350 MERRIMACK STREET
LAWRENCE, MA 01843
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments76,28762,61964,92862,97962,83955,455
Cash and cash equivalents76,28762,61964,92862,97962,83955,455
Receivables34,50638,68931,62530,24531,90039,260
Inventory, net of allowances, customer advances and progress billings50,31852,11849,21250,66851,23048,514
Inventory50,31852,11849,21250,66851,23048,514
Other undisclosed current assets8,3109,7957,6098,0399,4977,999
Total current assets:169,421163,221153,374151,931155,466151,228
Noncurrent Assets
Property, plant and equipment55,48459,45860,26262,21262,68461,323
Intangible assets, net (including goodwill)49,38749,90250,40850,91751,32351,828
Goodwill42,74842,74842,74842,74842,64842,648
Intangible assets, net (excluding goodwill)6,6397,1547,6608,1698,6759,180
Deferred costs32,49331,56831,41031,12531,61032,027
Other noncurrent assets6,2036,3605,9115,3762,9732,975
Other undisclosed noncurrent assets23,84823,44624,26423,79324,51224,395
Total noncurrent assets:167,415170,734172,255173,423173,102172,548
TOTAL ASSETS:336,836333,955325,629325,354328,568323,776
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities46,10541,63642,77041,49641,92943,252
Accounts payable14,95815,44314,78512,87114,99618,490
Accrued liabilities31,14726,19327,98528,62526,93324,762
Debt991051019995334
Other liabilities4,1854,7164,5594,6024,4814,111
Total current liabilities:50,38946,45747,43046,19746,50547,697
Noncurrent Liabilities
Long-term debt and lease obligation4545225205515531,240
Long-term debt, excluding current maturities4545225205515531,240
Liabilities, other than long-term debt64,72365,49164,69865,41665,35664,008
Deferred revenue and credits47,55947,20546,87447,42247,65847,773
Other liabilities17,16418,28617,82417,99417,69816,235
Total noncurrent liabilities:65,17766,01365,21865,96765,90965,248
Total liabilities:115,566112,470112,648112,164112,414112,945
Temporary equity, carrying amount(197)(171)(165)650(22)26
Equity
Equity, attributable to parent220,826221,383213,158213,324216,321210,508
Common stock686767676766
Treasury stock, value(20,170)(19,957)(19,283)(18,955)(18,708)(18,479)
Additional paid in capital665,186660,769657,640653,431647,343640,907
Accumulated other comprehensive loss(4,578)(2,514)(3,673)(1,895)(1,502)(3,196)
Accumulated deficit(419,680)(416,982)(421,593)(419,324)(410,879)(408,790)
Equity, attributable to noncontrolling interest641273(12)(784)(145)297
Total equity:221,467221,656213,146212,540216,176210,805
TOTAL LIABILITIES AND EQUITY:336,836333,955325,629325,354328,568323,776

Income Statement (P&L) ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Revenues
(Revenue, Net)
106,970107,298103,60197,29596,21696,829
Cost of revenue
(Cost of Goods and Services Sold)
(61,023)(61,133)(58,276)(56,688)(55,050)(55,639)
Gross profit:45,94746,16545,32540,60741,16641,190
Operating expenses(47,036)(47,295)(47,156)(48,890)(43,222)(42,871)
Operating income (loss):(1,089)(1,130)(1,831)(8,283)(2,056)(1,681)
Nonoperating income (expense)(760)(404)(459)(142)(545)(473)
Other nonoperating income (expense)(672)(295)(298)26(321)(270)
Income (loss) from continuing operations before income taxes:(1,849)(1,534)(2,290)(8,425)(2,601)(2,154)
Income tax expense (benefit)(372)(264)(21)(469)22613
Income (loss) from continuing operations:(2,221)(1,798)(2,311)(8,894)(2,579)(1,541)
Income (loss) before gain (loss) on sale of properties:(2,221)(1,798)(2,311)(8,894)(2,579)(1,541)
Net income (loss):(2,221)(1,798)(2,311)(8,894)(2,579)(1,541)
Net income (loss) attributable to noncontrolling interest(368)33942449490352
Net income (loss) attributable to parent:(2,589)(1,459)(2,269)(8,445)(2,089)(1,189)
Preferred stock dividends and other adjustments   (481)  
Net income (loss) available to common stockholders, diluted:(2,589)(1,459)(2,269)(8,926)(2,089)(1,189)

Comprehensive Income ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Net income (loss):(2,221)(1,798)(2,311)(8,894)(2,579)(1,541)
Other comprehensive income (loss)(2,064)1,159(1,778)(393)1,6942,905
Comprehensive income (loss):(4,285)(639)(4,089)(9,287)(885)1,364
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(368)33942449490352
Comprehensive income (loss), net of tax, attributable to parent:(4,653)(300)(4,047)(8,838)(395)1,716

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: